Apollo Medical Holdings, Inc.AMEHNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank50
3Y CAGR-55.0%
5Y CAGR-37.2%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
-55.0%/yr
vs -13.1%/yr prior
5Y CAGR
-37.2%/yr
Recent deceleration
Acceleration
-41.9pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
4 yr
Consecutive declineContracting
PeriodValueYoY Change
20251.06%-68.6%
20243.38%-63.4%
20239.25%-20.6%
202211.65%-4.2%
202112.17%+11.9%
202010.88%+100.0%
2019-1173701.42%-5741155.2%
201820.44%+28.4%
201715.92%+192.6%
2016-17.20%-